Estrella Immunopharma, Inc.ESLANASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank50
3Y CAGR+223.7%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
+223.7%/yr
Annual compound
Percentile
P50
Within normal range
vs 3Y Ago
33.9x
Strong expansion
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
2025$1.38M+51.0%
2024$916916.00-78.0%
2023$4.17M+10108.9%
2022$40802.00-99.0%
2021$4.09M-